Karyopharm Therapeutics Inc
NASDAQ:KPTI

Watchlist Manager
Karyopharm Therapeutics Inc Logo
Karyopharm Therapeutics Inc
NASDAQ:KPTI
Watchlist
Price: 1.15 USD 1.32% Market Closed
Updated: May 18, 2024

Karyopharm Therapeutics Inc
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Karyopharm Therapeutics Inc
Cash from Investing Activities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Karyopharm Therapeutics Inc
NASDAQ:KPTI
Cash from Investing Activities
$62.3m
CAGR 3-Years
20%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Cash from Investing Activities
-$11.1B
CAGR 3-Years
34%
CAGR 5-Years
-80%
CAGR 10-Years
-23%
Gilead Sciences Inc
NASDAQ:GILD
Cash from Investing Activities
-$3.6B
CAGR 3-Years
39%
CAGR 5-Years
N/A
CAGR 10-Years
-84%
Amgen Inc
NASDAQ:AMGN
Cash from Investing Activities
-$27.8B
CAGR 3-Years
-72%
CAGR 5-Years
N/A
CAGR 10-Years
-10%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Cash from Investing Activities
-$3.4B
CAGR 3-Years
-705%
CAGR 5-Years
-69%
CAGR 10-Years
-57%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Cash from Investing Activities
-$4.6B
CAGR 3-Years
-89%
CAGR 5-Years
-21%
CAGR 10-Years
-26%

See Also

What is Karyopharm Therapeutics Inc's Cash from Investing Activities?
Cash from Investing Activities
62.3m USD

Based on the financial report for Mar 31, 2024, Karyopharm Therapeutics Inc's Cash from Investing Activities amounts to 62.3m USD.

What is Karyopharm Therapeutics Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 3Y
20%

The average annual Cash from Investing Activities growth rates for Karyopharm Therapeutics Inc have been 20% over the past three years .